282.84MMarket Cap
LossP/E TTM
Editas Medicine Inc's Company Valuation
Currency: USD Updated: 2026-06-23The current valuation score of Editas Medicine Inc is 7.00, ranking 256 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.42, which is -86.65% below the recent high of -0.32 and -127.23% above the recent low of -5.49.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.